Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over time J.M. Carrascosa, N. Rivera, I. Garcia-Doval, G. Carretero, F. Vanaclocha, E. Daudén, F.J. Gómez-García, P. De-la-Cueva-Dobao, E. Herrera-Ceballos, I. Belinchón, M. Alsina, J.L. Sánchez-Carazo, M. Ferrán, J.L. Lopez-Estebaranz, B. Pérez-Zafrilla, M. Llamas, R. Rivera, C. Ferrándiz

Gender at Dermatology Conferences: A Descriptive Analysis A. López Valle, C.A. Rubio-Muniz

Measurement Assessment of Minimal Disease Activity in Psoriasis in Spain: A National Cross-Sectional Study G. Carretero Hernández, M. Ara Martín, S. Armesto Alonso, I. Belinchón Romero, N. Eiris Salvado, M. Ferrán Farrés, C. Galache Osuna, M. García Bustínduy, J. García Latasa de Araníbar, M. Juliá Manresa, M. Llamas Velasco, A. López Ferrer, M. Roncero Riesco, D. Ruiz Genao, R. Ruíz-Villaverde, L. Salgado Boquete, C. Soria Martínez, E. Vilarrasa Rull, M.A. Descalzo